JAMA Network August 30, 2022
David M. Levine, MD, MPH, MA; Mary Paz, BA; Kimberly Burke, BA; Ryan Beaumont, BS; Robert B. Boxer, MD, PhD1,2; Charles A. Morris, MD, MPH; Kathryn A. Britton, MD, MPH; E. John Orav, PhD; Jeffrey L. Schnipper, MD, MPH

A Randomized Clinical Trial

Key Points

Question When a patient receives acute hospital-level care at home (home hospital), is the use of remote physician visits noninferior to in-home physician visits in terms of safety and patient experience?

Findings In this 2-site randomized clinical trial of 172 patients, the mean adverse event count was 6.8 per 100 patients for patients receiving remote care vs 3.9 per 100 patients for control patients, for a difference of 2.8, supporting noninferiority, although 19% of patients receiving remote care required in-home physician visits. Patient experience was noninferior.

Meaning In this study, remote physician visits were noninferior to in-home physician visits during home hospital care for adverse events and patient experience, although in-home physician care was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Healthcare System, Home, Patient / Consumer, Physician, Provider, Safety, Survey / Study, Trends
Lee Health to launch hospital-at-home program
10 health systems grow hospital at home
The Benefits of Receiving Care in the Comfort of Your Own Home
UF Health unveils hospital at home
Appleā€™s AI-Powered Smart Home Hub May Include eCommerce Capabilities

Share This Article